BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35118344)

  • 1. Thoracic SMARCA4-deficient undifferentiated tumor-a case of an aggressive neoplasm-case report.
    Roden AC
    Mediastinum; 2021; 5():39. PubMed ID: 35118344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent updates in thoracic SMARCA4-deficient undifferentiated tumor.
    Nambirajan A; Jain D
    Semin Diagn Pathol; 2021 Sep; 38(5):83-89. PubMed ID: 34147303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
    Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
    Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Subset of Thoracic SMARCA4-Deficient Undifferentiated Tumors Express GATA3.
    Coconubo DM; Wangsiricharoen S; Pettus JR; Linos K; Pinto A; Wang WL; Kerr DA; Cloutier JM
    Int J Surg Pathol; 2024 Jun; 32(4):684-691. PubMed ID: 37461275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thoracic
    Xiong Y; Zhang B; Nie LG; Wu SK; Zhao H; Li D; DI JT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):351-356. PubMed ID: 37042149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thoracic SMARCA4-Deficient Undifferentiated Tumors With Unusual Presentations: A Case Series.
    Helmink AJ; Alshomrani A; Lauer SR; Yuil-Valdes A
    Int J Surg Pathol; 2023 Oct; ():10668969231206350. PubMed ID: 37903457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy and Immune Checkpoint Inhibitors in a Case of SMARCA4-dUT: A Case Report and Review of Literature.
    Pokhrel A; Yadav R; Manvar KK; Wu R; Jaswani V; Wasserman CB; Wang JC
    J Investig Med High Impact Case Rep; 2023; 11():23247096231176220. PubMed ID: 37269109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor.
    Zhou P; Fu Y; Tang Y; Jiang L; Wang W
    PeerJ; 2024; 12():e16923. PubMed ID: 38374950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.
    Nambirajan A; Dutta R; Malik PS; Bubendorf L; Jain D
    Acta Cytol; 2021; 65(1):67-74. PubMed ID: 32854100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
    Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
    Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thoracic SMARCA2-deficient But SMARCA4-preserved Tumors With Undifferentiated Morphology Combined With Claudin-4 Negativity.
    Iwakoshi A; Sasaki E; Sato M; Sugiyama K; Kogure Y; Kitagawa C; Nishimura R
    Am J Surg Pathol; 2022 Jul; 46(7):1000-1006. PubMed ID: 35220352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of surgically treated non-metastatic SMARCA4-deficient undifferentiated thoracic tumor: a case report and literature review.
    Yin C; Liu ZJ; He C; Yu HX
    Front Oncol; 2024; 14():1399868. PubMed ID: 38903719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of cell block examination for the cytological diagnosis of thoracic SMARCA4-deficient undifferentiated tumor: A case report.
    Minoshima A; Sugita S; Segawa K; Aoyama T; Ito M; Daimon F; Takenami T; Kido T; Moriya J; Nishikiori H; Hasegawa T
    Diagn Cytopathol; 2023 May; 51(5):E149-E154. PubMed ID: 36772934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics.
    Al-Shbool G; Krishnan Nair H
    Cureus; 2022 Oct; 14(10):e30708. PubMed ID: 36439610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Under the Microscope: A Case Report of Thoracic SMARCA4-Deficient Undifferentiated Tumor with Review of the Literature.
    Mundada M; Mannan KA; Vasu D; Ahmed F; K S
    Turk Patoloji Derg; 2024; 40(2):128-133. PubMed ID: 38265099
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kwon HJ; Jang MH
    World J Clin Cases; 2023 Apr; 11(11):2521-2527. PubMed ID: 37123323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous Malignant Gastrointestinal Neuroectodermal Tumor and SMARCA4-Deficient Undifferentiated Carcinoma With Independent Origins in the Small Intestine: A Case Report.
    Chen C; Yin W; Wang X; Li P; Chen Y; Jin X; Yang P; Wu H
    Front Oncol; 2021; 11():665056. PubMed ID: 34513665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMARCA4-Deficient Undifferentiated Tumor Diagnosed on Adrenal Sampling.
    Ashour S; Reynolds JP; Mukhopadhyay S; McKenney JK
    Am J Clin Pathol; 2022 Jan; 157(1):140-145. PubMed ID: 34463317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SMARCA4-deficient undifferentiated carcinoma of the gastrointestinal tract: a clinicopathological and immunohistochemical study of nine cases].
    Zhu PP; Li XX; Liu JH; Du XL; Su HY; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):868-874. PubMed ID: 36097904
    [No Abstract]   [Full Text] [Related]  

  • 20. Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunotherapy efficacy.
    Zhou P; Fu Y; Tang Y; Jiang L; Wang W
    Lung Cancer; 2024 Mar; 189():107471. PubMed ID: 38306886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.